4'-(2-(1-(carboxymethyl)-5-neopentyl-1H-imidazol-2-yl)ethyl)biphenyl-2-carboxylic acid

ID: ALA4590481

Chembl Id: CHEMBL4590481

PubChem CID: 155568183

Max Phase: Preclinical

Molecular Formula: C25H28N2O4

Molecular Weight: 420.51

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)Cc1cnc(CCc2ccc(-c3ccccc3C(=O)O)cc2)n1CC(=O)O

Standard InChI:  InChI=1S/C25H28N2O4/c1-25(2,3)14-19-15-26-22(27(19)16-23(28)29)13-10-17-8-11-18(12-9-17)20-6-4-5-7-21(20)24(30)31/h4-9,11-12,15H,10,13-14,16H2,1-3H3,(H,28,29)(H,30,31)

Standard InChI Key:  JXGFINYBBJLOJI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4590481

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.51Molecular Weight (Monoisotopic): 420.2049AlogP: 4.71#Rotatable Bonds: 8
Polar Surface Area: 92.42Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.60CX Basic pKa: 7.54CX LogP: 3.69CX LogD: 0.62
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.55Np Likeness Score: -0.63

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source